SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
Project Number5R01CA072684-03
Contact PI/Project LeaderJUNG, MICHAEL E
Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
The purpose of this proposed research program is to develop new general
methods for the construction of polypropionate natural products. The key
step in the syntheses of these compounds involves a concerted Lewis acid-
promoted rearrangement of an optically active epoxy alcohol to generate
an 2-methyl-3-trialkylsilyloxy-alkanals, namely an aldol product by a
non-aldol route. We have shown that all four possible enantiomers can be
easily prepared in high optical purity and good yields by this approach.
We plan to extend this research to prepare polypropionate chains with
various absolute stereochemistries. In particular, in order to illustrate
the efficiency of this process, we will synthesize the two extremely
strongly cytotoxic agents, 13-deoxytedanolide 1 and tedanolide 2, and
their close structural analogues and diastereomers, by an application of
this new approach to polypropionates. 13-deoxytedanolide is extremely
cytotoxic [IC50 94 pg/ml (P388)] and has high antitumor activity [T/C
189% (P388) at 125 mug/kg] while tedanolide is also extremely tumor
inhibitory [ED50's 250 pg/ml (KB) and 16 pg/ml (PS)] and causes
accumulation of cells in the S phase at very low concentrations (10
ng/ml). Thus they are very promising leads as new agents for cancer
treatment. The development of good general routes for their synthesis
would not only provide a potentially useful preparation of them (both
were isolated from marine sponges and are present in very small
quantities) but also would allow one to prepare several structural
analogues unavailable from natural sources which may show enhanced
chemotherapeutic properties. We intend to make several analogues (e.g.,
the 13-epimer of 2, analogues with shorter side chain and ones with
different groups and/or stereochemistries). All of the advanced synthetic
materials will be tested for antitumor activity. In this way, we hope to
figure out just what parts of this complex molecule are required for the
potent antitumor activity and hopefully to prepare some simpler
structures which still show reasonable activity. The successful
accomplishment of the research described in this proposal - namely, the
development of a really useful synthetic route to polypropionates and the
synthesis of the potent cytotoxic agents 13-deoxytedanolide 1 and
tedanolide 2 and their analogues - would be of great significance to
medicinal chemistry. Because of the medicinal importance of the targets,
the efficiency of bond construction in the syntheses, and the high
intrinsic value of the new methods themselves, the likelihood of an
important contribution to health-related science is quite high.
No Sub Projects information available for 5R01CA072684-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA072684-03
Patents
No Patents information available for 5R01CA072684-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA072684-03
Clinical Studies
No Clinical Studies information available for 5R01CA072684-03
News and More
Related News Releases
No news release information available for 5R01CA072684-03
History
No Historical information available for 5R01CA072684-03
Similar Projects
No Similar Projects information available for 5R01CA072684-03